pqq cofactor has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies
PQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lu, J | 1 |
Chen, S | 1 |
Shen, M | 1 |
He, Q | 1 |
Zhang, Y | 1 |
Shi, Y | 1 |
Ding, F | 2 |
Zhang, Q | 2 |
Zhang, J | 1 |
Jiang, C | 1 |
Qin, J | 1 |
Ke, K | 1 |
2 other studies available for pqq cofactor and Autosomal Dominant Juvenile Parkinson Disease
Article | Year |
---|---|
Mitochondrial regulation by pyrroloquinoline quinone prevents rotenone-induced neurotoxicity in Parkinson's disease models.
Topics: Animals; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Insecticides; Mitochondria; Par | 2018 |
Involvement of ERK1/2 pathway in neuroprotective effects of pyrroloquinoline quinine against rotenone-induced SH-SY5Y cell injury.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Survival; DNA, Mitochondrial; Electron | 2014 |